FDA device listing
(anti-phosphatidylserineand prothombin),QUANTA Lite aPS/PT IgG ELISA,QUANTA Lite aPS/PT IgM ELISA
FDA device listing 1427979194 · INOVA DIAGNOSTICS, INC.
Key facts
| Proprietary names | (anti-phosphatidylserineand prothombin),QUANTA Lite aPS/PT IgG ELISA,QUANTA Lite aPS/PT IgM ELISA |
|---|---|
| Owner/operator | INOVA DIAGNOSTICS, INC. |
| Owner/operator number | 2026994 |
| Premarket submissions | K090755 |
| Product codes | OPN |
| Device names | OPN - Auto-Antibodies; Phosphatidylserine, Prothrombin, Phosphatidylserine/Prothrombin Complex |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.5660 |
| Review panels | Immunology |
| Registered establishments | INOVA DIAGNOSTICS, INC. |
| Establishment registrations | 2026994 |
| FEI numbers | 2026994 |
| Establishment operations | Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 100–999 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database